Medical Science News

RSS

New research shows inner voice plays a key role in controlling impulsive behaviour

New research out of the University of Toronto Scarborough - published in this month's edition of Acta Psychologica - shows that using your inner voice plays an important role in controlling impulsive behaviour.

22 Sep 2010

Researchers explain how nerve cells transmit electrical signals

Billions of brain cells are communicating at any given moment. Like an organic supercomputer they keep everything going, from breathing to solving riddles, and "programming errors" can lead to serious conditions such as schizophrenia, Parkinson's disease and attention-deficit hyperactivity disorder.

22 Sep 2010

Rush University researchers identify potential new way to prevent Alzheimer's disease progression

Neurological researchers at Rush University Medical Center have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease. The target called neutral sphingomyelinase (N-SMase) is a protein that when activated, can cause a chain of reactions in the cell leading to neuronal death and memory loss.

22 Sep 2010

QR Pharma and MUSC receive $220,000 SBIR grant to study Posiphen in AD transgenic mice

QR Pharma, Inc., a clinical-stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of cognitive impairment and Alzheimer's disease and the Medical University of South Carolina (MUSC) announced today that they received a Small Business Innovation Research (SBIR) phase I grant in the amount of $220,000 to study Posiphen® and its metabolites in cell culture and in transgenic Alzheimer mice.

22 Sep 2010

NIH awards UCSF $15.4 million to set up new National Center for Systems Biology

Cell biologists at UCSF have received $15.4 million from the National Institutes of Health to set up one of two new National Centers for Systems Biology, to study how cells respond to their environment - an emerging field of research that could revolutionize medicine by creating "smart cells" to deliver medications and other therapeutics more effectively.

22 Sep 2010

FDA grants Phadia 510(k) clearance for CLIA Moderate Complexity, EliA autoimmune antibody assays

Today Phadia announced that it has received FDA 510(k) clearance for two new, CLIA Moderate Complexity, EliA autoimmune antibody assays. The new assays will provide physicians with additional tools needed to aid in the diagnosis of Celiac disease. The newly available assays, EliA GliadinDP IgA and EliA GliadinDP IgG (deamidated peptides), have proven to be essential, sensitive and specific markers to aid in the diagnosis of celiac disease.

22 Sep 2010

Brown grants exclusive intellectual property license to Tivorsan Pharmaceuticals

Development of a potential treatment for the most common form of muscular dystrophy is moving into a new phase at Brown University. Brown has granted an exclusive license for the intellectual property to Tivorsan Pharmaceuticals, a startup firm that will strive to see it through human trials.

22 Sep 2010

Semantic Stimuli Response Measurement technology measures response of subconscious mind

The National Mental Health Association reports that over 65 million Americans suffer from some type of mental illness and that 1 in 5 people will experience some mental illness during their life. By 2020, mental illness is projected to be the leading cause of disease burden in North America, an obviously staggering problem with total costs to society running into the hundreds of billions every year.

21 Sep 2010

New genes associated with osteoarthritis progression

Scientists from University of North Carolina at Chapel Hill School of Medicine and Interleukin Genetics, Inc. announced today findings from a large clinical study to evaluate the role played by genetic factors in the worsening of osteoarthritis.

21 Sep 2010

ChemoCentryx presents CCX140 clinical data at EASD

ChemoCentryx, Inc., today announced that it reported positive preclinical and Phase I study results at the European Association for the Study of Diabetes (EASD). CCX140, a novel, orally bioavailable small molecule antagonist of the chemokine receptor CCR2, improved metabolic function while significantly reducing inflammatory macrophages found in adipose tissue in an animal model, and was well tolerated in Phase I clinical trials.

21 Sep 2010

Brain wolfs energy even to stop thinking

Ever wonder why it's such an effort to forget about work while on vacation or to silence that annoying song that's playing over and over in your head?

21 Sep 2010

ASM awards UTHealth student 3-year, $33,000 fellowship for study of molecular details of protein folding in cells

Jennifer Abrams, a graduate student at The University of Texas Health Science Center at Houston (UTHealth), has been awarded a three-year, $33,000 fellowship from the American Society for Microbiology (ASM) to support her innovative research into the molecular causes of protein misfolding diseases like Alzheimer's, Lou Gehrig's and Parkinson's.

21 Sep 2010

Social exclusion induces people to spend money and consume in service of affiliation

People who feel excluded will go to any length to try to become part of a group, even if it involves spending large sums of cash, eating something dicey, or doing illicit drugs, according to a new study in the Journal of Consumer Research.

21 Sep 2010

Researchers to develop vaccine for plague

Given the many pressing concerns of the day, fear of plague probably isn't what causes most Americans to lose sleep. But for those whose responsibility it is to combat bioterrorism, plague is among the highest priorities. Those charged with that mission include scientists like medical researcher Steve Smiley, whose lab at the Trudeau Institute is working to develop a vaccine that will protect the public against weaponized forms of plague.

21 Sep 2010

Alpha-synuclein protein in Parkinson's disease inhibits autophagy: Research

A protein linked to Parkinson's disease may cause neurodegeneration by inhibiting autophagy-the process in which cells digest some of their contents-according to a study in the September 20 issue of the Journal of Cell Biology

21 Sep 2010

Researchers discover new drug to control acute and chronic pain

American and Italian researchers have found that a novel drug allows anandamide a marijuana like chemical in the body to effectively control pain at the site of an injury.

21 Sep 2010

National Science Foundation awards UofL researcher $500,000 for nervous system study

Michal Hetman, MD, PhD, associate professor and endowed chair in molecular signaling in the Kentucky Spinal Cord Injury Research Center and the UofL Department of Neurological Surgery, has received a three-year, $500,000 grant from the National Science Foundation to fund a project that will aim to explain how the nervous system grows and develops.

21 Sep 2010

Scientists identify new pathway to control immune balance

St. Jude Children's Research Hospital scientists have identified a new pathway that helps control the immune balance through reciprocal regulation of specialized T lymphocytes, which play very different inflammatory roles.

21 Sep 2010

Trius and Scripps to develop antibiotics from marine biomedical sources

In an effort to tap into the vast potential of the oceans as a source for novel medical treatments, the Defense Threat Reduction Agency (DTRA), a part of the Department of Defense (DoD), has awarded San Diego-based Trius Therapeutics, Inc. a four-and-a-half year contract worth up to $29.5 million to collaborate with Scripps Institution of Oceanography at UC San Diego for the development of novel antibiotics directed against microorganisms that cause serious infections.

21 Sep 2010

High screen use increases body fat in teenagers

Too much television, video games and Internet can increase body fat in teens. A five-year study from the University of Montreal and the Sainte-Justine Hospital Research Center, published in the American Journal of Epidemiology, has found teenagers have four different patterns of screen use: increasers, decreasers, consistently high and consistently low users.

21 Sep 2010

Medical Science News

New research shows inner voice plays a key role in controlling impulsive behaviour

Researchers explain how nerve cells transmit electrical signals

Rush University researchers identify potential new way to prevent Alzheimer's disease progression

QR Pharma and MUSC receive $220,000 SBIR grant to study Posiphen in AD transgenic mice

NIH awards UCSF $15.4 million to set up new National Center for Systems Biology

FDA grants Phadia 510(k) clearance for CLIA Moderate Complexity, EliA autoimmune antibody assays

Brown grants exclusive intellectual property license to Tivorsan Pharmaceuticals

Semantic Stimuli Response Measurement technology measures response of subconscious mind

New genes associated with osteoarthritis progression

ChemoCentryx presents CCX140 clinical data at EASD

Brain wolfs energy even to stop thinking

ASM awards UTHealth student 3-year, $33,000 fellowship for study of molecular details of protein folding in cells

Social exclusion induces people to spend money and consume in service of affiliation

Researchers to develop vaccine for plague

Alpha-synuclein protein in Parkinson's disease inhibits autophagy: Research

Researchers discover new drug to control acute and chronic pain

National Science Foundation awards UofL researcher $500,000 for nervous system study

Scientists identify new pathway to control immune balance

Trius and Scripps to develop antibiotics from marine biomedical sources

High screen use increases body fat in teenagers

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News